WTWeiyan Tu

Weiyan Tu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weiyan Tu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Ning

    Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University

    1 shared publication
  • Meijing Wu

    Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University

    1 shared publication
  • Menglu Qin

    Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China

    1 shared publication
  • Na Luo

    Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University

    1 shared publication
  • Rongdi Xu

    Department of Obstetrics, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University

    1 shared publication
  • Weimin Wu

    Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Chinese visceral adiposity index outperforms insulin resistance indices in predicting cardiovascular disease risk: a 12-year prospective cohort study

    by Weiyan Tu, Rongdi Xu, Na Luo, Meijing Wu, Yong Zhou, Jing Ning

    Aims: This study investigated and compared the abilities of seven insulin resistance (IR) indices, including the triglyceride-glucose index (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-hip ratio (TyG-WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), Chinese visceral adiposity index (CVAI), and metabolic score for insulin resistance (METS-IR) to predict cardiovascular disease (CVD) among participants without a history of CVD. Methods: The population was recruited from the prospective Asymptomatic Polyvascular Abnormalities Community (APAC) Study in Hebei. This prospective study included 5,194 individuals without history of CVD who were stratified into CVD group and non-CVD group. The seven IR indices (TyG, TyG-WC, TyG-WHtR, LAP, VAI, CVAI, and METS-IR) were calculated. The primary endpoint was CVD. Results: Over a 12-year follow-up period, 373(7.2%) CVD were documented. The seven IR indices were strongly positively associated with CVD risk. Compare to other IR indices, CVAI was the strongest predictor for CVD (HR:1.84 95% CI: 1.45–2.35; p < 0.001) and showed the highest diagnostic value for CVD (AUC: 0.654 95% CI: 0.640–0.666; p < 0.001). Adding CVAI to the based model exhibited the maximum increased on incremental risk stratification for CVD (NRI: 0.355; IDI: 0.010; all p < 0.001). Moreover, there was a non-linear association between CVAI and CVD, with a threshold point of 96.21. The association between CVAI and CVD risk was more prominent among individuals aged<65 years, female, and non-hypertension (all P interaction<0.001). Conclusion: Compared to the other six tested IR indices, CVAI might be the most valuable index to predict and stratify CVD risk, with enhanced prediction in women under 65 years of age. This suggests that strategies aimed at improving risk stratification should incorporate CVAI into risk algorithms.

  • Open Access

    Metformin regulates autophagy via LGMN to inhibit choriocarcinoma

    by Weiyan Tu, Menglu Qin, Yu Li, Weimin Wu, Xiaowen Tong